MX2009007572A - Proteinas de fusion que contienen los antigenos de rechazo de tumor ny-eso-1 y. - Google Patents
Proteinas de fusion que contienen los antigenos de rechazo de tumor ny-eso-1 y.Info
- Publication number
- MX2009007572A MX2009007572A MX2009007572A MX2009007572A MX2009007572A MX 2009007572 A MX2009007572 A MX 2009007572A MX 2009007572 A MX2009007572 A MX 2009007572A MX 2009007572 A MX2009007572 A MX 2009007572A MX 2009007572 A MX2009007572 A MX 2009007572A
- Authority
- MX
- Mexico
- Prior art keywords
- fusion protein
- antigen
- proteins
- fusion proteins
- fusion
- Prior art date
Links
- 102000037865 fusion proteins Human genes 0.000 title abstract 3
- 108020001507 fusion proteins Proteins 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 abstract 1
- 102100039510 Cancer/testis antigen 2 Human genes 0.000 abstract 1
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 abstract 1
- 101000889345 Homo sapiens Cancer/testis antigen 2 Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001188—NY-ESO
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0700759A GB0700759D0 (en) | 2007-01-15 | 2007-01-15 | Novel fusion protein |
| US91492507P | 2007-04-30 | 2007-04-30 | |
| US91484807P | 2007-04-30 | 2007-04-30 | |
| GB0709707A GB0709707D0 (en) | 2007-05-21 | 2007-05-21 | Novel fusion protein |
| PCT/US2008/050879 WO2008089074A2 (en) | 2007-01-15 | 2008-01-11 | Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009007572A true MX2009007572A (es) | 2009-10-13 |
Family
ID=41111108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009007572A MX2009007572A (es) | 2007-01-15 | 2008-01-11 | Proteinas de fusion que contienen los antigenos de rechazo de tumor ny-eso-1 y. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2118128B1 (enExample) |
| JP (1) | JP2010532656A (enExample) |
| KR (1) | KR20090122426A (enExample) |
| BR (1) | BRPI0806501A2 (enExample) |
| CA (1) | CA2674458A1 (enExample) |
| DK (1) | DK2118128T3 (enExample) |
| EA (1) | EA016818B1 (enExample) |
| ES (1) | ES2398492T3 (enExample) |
| HR (1) | HRP20130022T1 (enExample) |
| MX (1) | MX2009007572A (enExample) |
| PE (1) | PE20081687A1 (enExample) |
| PL (1) | PL2118128T3 (enExample) |
| SI (1) | SI2118128T1 (enExample) |
| TW (1) | TW200902049A (enExample) |
| WO (1) | WO2008089074A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008308474A (ja) * | 2007-06-18 | 2008-12-25 | Nitto Denko Corp | 抗原ペプチド製剤の調製方法 |
| SG174877A1 (en) | 2009-03-17 | 2011-11-28 | Mdxhealth Sa | Improved detection of gene expression |
| GB0910046D0 (en) | 2009-06-10 | 2009-07-22 | Glaxosmithkline Biolog Sa | Novel compositions |
| AU2012302778B2 (en) * | 2011-08-31 | 2016-11-24 | Mie University | Vaccine preparation for cancer treatment |
| GB201116248D0 (en) | 2011-09-20 | 2011-11-02 | Glaxosmithkline Biolog Sa | Liposome production using isopropanol |
| EP3604271A1 (en) | 2013-06-28 | 2020-02-05 | Auckland Uniservices Limited | Peptides for amino acid and peptide conjugates and conjugation process |
| US20160367651A1 (en) | 2013-10-01 | 2016-12-22 | Mie University | T cell inducing vaccine containing an interepitope sequence that promotes antigen presentation |
| CN107250103A (zh) | 2014-12-23 | 2017-10-13 | 玛格丽特·安妮·布林布尔 | 氨基酸缀合物和肽缀合物以及其用途 |
| AU2017216653B2 (en) | 2016-02-08 | 2021-12-23 | Kyoto University | Pretreatment drug for T cell infusion therapy for immune-checkpoint inhibitor-resistant tumor |
| TW201735952A (zh) | 2016-02-26 | 2017-10-16 | 瑪格蕾特 安 布萊博 | 胺基酸及肽共軛物以及共軛過程 |
| ES3016535T3 (en) * | 2018-11-23 | 2025-05-09 | Strike Pharma Ab | Bi-specific conjugates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06205672A (ja) * | 1992-03-19 | 1994-07-26 | Nippon Zeon Co Ltd | 日本脳炎ウイルス及びｂ型肝炎ウイルスの表面抗原タンパク質の抗原部位を持つキメラタンパク質の製造法、およびそれに用いる組み換えバキュロウイルス |
| US6686147B1 (en) * | 1998-07-15 | 2004-02-03 | Ludwig Institute For Cancer Research | Cancer associated antigens and uses therefor |
| ATE507295T1 (de) * | 2000-03-30 | 2011-05-15 | Dendreon Corp | Zusammensetzungen und verfahren für eine auf dendritischen zellen basierende immuntherapie |
| US20030044813A1 (en) * | 2001-03-30 | 2003-03-06 | Old Lloyd J. | Cancer-testis antigens |
| EP1708741B1 (en) * | 2003-12-24 | 2016-03-30 | Aduro Biotech | Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof |
| GB0409940D0 (en) * | 2004-05-04 | 2004-06-09 | Glaxosmithkline Biolog Sa | Vaccine |
| CN102220357B (zh) * | 2004-11-16 | 2013-12-25 | 克鲁塞尔荷兰公司 | 包含重组病毒载体的多价疫苗 |
| CA2653402A1 (en) * | 2006-05-26 | 2007-12-06 | Glaxosmithkline Biologicals S.A. | Method |
| PT2114993E (pt) * | 2007-01-15 | 2012-11-28 | Glaxosmithkline Biolog Sa | Vacina |
-
2008
- 2008-01-11 ES ES08727588T patent/ES2398492T3/es active Active
- 2008-01-11 WO PCT/US2008/050879 patent/WO2008089074A2/en not_active Ceased
- 2008-01-11 EP EP08727588A patent/EP2118128B1/en not_active Not-in-force
- 2008-01-11 DK DK08727588.9T patent/DK2118128T3/da active
- 2008-01-11 EA EA200900738A patent/EA016818B1/ru not_active IP Right Cessation
- 2008-01-11 KR KR1020097016892A patent/KR20090122426A/ko not_active Ceased
- 2008-01-11 TW TW097101220A patent/TW200902049A/zh unknown
- 2008-01-11 PL PL08727588T patent/PL2118128T3/pl unknown
- 2008-01-11 MX MX2009007572A patent/MX2009007572A/es active IP Right Grant
- 2008-01-11 JP JP2009545705A patent/JP2010532656A/ja active Pending
- 2008-01-11 PE PE2008000128A patent/PE20081687A1/es not_active Application Discontinuation
- 2008-01-11 HR HRP20130022AT patent/HRP20130022T1/hr unknown
- 2008-01-11 BR BRPI0806501-2A2A patent/BRPI0806501A2/pt not_active IP Right Cessation
- 2008-01-11 SI SI200830870T patent/SI2118128T1/sl unknown
- 2008-01-11 CA CA002674458A patent/CA2674458A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2398492T3 (es) | 2013-03-19 |
| WO2008089074A2 (en) | 2008-07-24 |
| EP2118128B1 (en) | 2012-11-07 |
| KR20090122426A (ko) | 2009-11-30 |
| PE20081687A1 (es) | 2008-12-25 |
| WO2008089074A3 (en) | 2008-12-31 |
| EA200900738A1 (ru) | 2010-02-26 |
| JP2010532656A (ja) | 2010-10-14 |
| HRP20130022T1 (hr) | 2013-02-28 |
| SI2118128T1 (sl) | 2013-02-28 |
| CA2674458A1 (en) | 2008-07-24 |
| EP2118128A2 (en) | 2009-11-18 |
| WO2008089074A9 (en) | 2012-07-12 |
| TW200902049A (en) | 2009-01-16 |
| PL2118128T3 (pl) | 2013-03-29 |
| DK2118128T3 (da) | 2013-02-18 |
| EA016818B1 (ru) | 2012-07-30 |
| BRPI0806501A2 (pt) | 2014-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009007572A (es) | Proteinas de fusion que contienen los antigenos de rechazo de tumor ny-eso-1 y. | |
| UA103751C2 (ru) | Иммуногенный пептид для иммунотерапии | |
| EP4364754A3 (en) | Anti-b7-h3 antibodies and antibody drug conjugates | |
| WO2007039192A3 (en) | Compositions and methods for treating tumors presenting survivin antigens | |
| CY1118492T1 (el) | Φαρμακοτεχνικες μορφες εμβολιου norovirus | |
| WO2006082406A3 (en) | Human antibodies and proteins | |
| BR122021020829B8 (pt) | Proteína de ligação ao fator h de ocorrência não natural (fhbp), composição, e célula hospedeira de neisseria meningitidis geneticamente modificada | |
| CY1120430T1 (el) | Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων | |
| WO2016176624A3 (en) | Porcine pestvirus, vaccines, and assays | |
| WO2007067681A3 (en) | Immunostimulatory compositions and methods | |
| TNSN07069A1 (en) | Process for concentration of antibodies and therapeutic products thereof | |
| WO2009133378A3 (en) | Products and methods for stimulating an immune response | |
| ZA202206809B (en) | Hiv vaccines comprising one or more population episensus antigens | |
| WO2014136064A3 (en) | Immunogenic fusion polypeptides | |
| WO2012054929A3 (en) | Use of human serum albumin to decrease antigenicity of therapeutic proteins | |
| WO2008124646A3 (en) | Use of amyloid proteins as vaccine scaffolds | |
| EP4374913A3 (en) | Novel human serum albumin mutant | |
| WO2008134643A3 (en) | Trypanosoma antigens, vaccine compositions, and related methods | |
| WO2012047267A3 (en) | Polyvalent immunogen | |
| NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller | |
| WO2020074908A3 (en) | Treatment and prevention of malaria based on the antigen pfrh5 and antibodies against the same | |
| PT1951300E (pt) | Modificação do equilíbrio de th1/th2 em vacinas da influenza fragmentadas com adjuvantes | |
| UA97092C2 (ru) | T-клеточные эпитопы с раково-эмбрионального антиген-незрелого рецепторного белка ламинина и их медицинское применение | |
| CY1125328T1 (el) | Ανασυνδυασμενο εμβολιο ιου λευχαιμιας αιλουροειδων περιεχοντας βελτιστοποιημενο γονιδιο φακελου ιου λευχαιμιας αιλουροειδων | |
| WO2012075104A3 (en) | Novel non-primate hepacivirus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HH | Correction or change in general | ||
| FG | Grant or registration |